Cargando…

Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study

BACKGROUND: Studies have reported that low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-infected patients; however, the factors that contribute to HIV-related BMD changes are yet to be fully understood. Due to the application of dual X-ray absorptiometry (DXA) among...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Yong-Qin, Xiao, Jiang, Li, Cui-Lin, Wang, Yu, Zhang, Ling, Pang, Xiao-Li, Wang, Di, Du, Juan, Zhao, Hong-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752695/
https://www.ncbi.nlm.nih.gov/pubmed/33278100
http://dx.doi.org/10.1097/CM9.0000000000001317
_version_ 1783625921768456192
author Zeng, Yong-Qin
Xiao, Jiang
Li, Cui-Lin
Wang, Yu
Zhang, Ling
Pang, Xiao-Li
Wang, Di
Du, Juan
Zhao, Hong-Xin
author_facet Zeng, Yong-Qin
Xiao, Jiang
Li, Cui-Lin
Wang, Yu
Zhang, Ling
Pang, Xiao-Li
Wang, Di
Du, Juan
Zhao, Hong-Xin
author_sort Zeng, Yong-Qin
collection PubMed
description BACKGROUND: Studies have reported that low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-infected patients; however, the factors that contribute to HIV-related BMD changes are yet to be fully understood. Due to the application of dual X-ray absorptiometry (DXA) among a select group of hospitals only, the prevalence and risk factors of low BMD in HIV-infected populations have not been intensively investigated in China. Thus, the aim of our study was to investigate the prevalence of and risk factors associated with BMD changes among antiretroviral therapy (ART)-naive HIV-positive patients in China. METHODS: The assessment of the prevalence of and risk factors associated with BMD changes was conducted among 156 ART-naive HIV-infected patients. Demographic and clinical data, as well as results of fasting blood tests were obtained from patients. Further, all patients underwent DXA scans to determine BMD, which was then used to classify patients with osteopenia/osteoporosis. The risk factors of reduced BMD were then evaluated using binary logistic regression. RESULTS: Among the 156 ART-naive HIV-infected participants, osteopenia and osteoporosis were diagnosed in 48.7% (76/156) and 4.5% (7/156) of patients, respectively. The lumbar spine was most likely to have reduced BMD (49.4% [77/156]), and the proportion of osteopenia in the left hip (32.7% [51/156]) was higher than in the right hip (24.4% [38/156]). In the lumbar spine, bone loss rate in the L1 section (60.9% [95/156]) was the most significant (L2, 53.2% [83/156]; L3, 45.5% [71/156]; L4, 52.6% [82/156]). Further analysis showed that, compared with the neck (26.9% [42/156] in the left, 18.6% [29/156] in the right) and the interior (15.4% [24/156] in the left, 13.5% [21/156] in the right), the trochanter had the greatest probability of reduced BMD (46.2% [72/156] in the left, 28.8% [45/156] in the right). In the risk factor analysis, low body mass index (BMI: <18.5 kg/m(2)) was positively associated with reduced BMD (Exp (B) = 39.743, 95% confidence interval: 3.234–488.399, P = 0.004), and was specifically positively correlated with BMD values at three sites (r = 0.335 at right hip, r = 0.327 at left hip, r = 0.311 at lumbar spine). CONCLUSION: Reduced BMD was found in the majority of ART-naive HIV-infected patients and BMI was identified as an additional risk factor for reduced BMD. Our results show that BMD reduction was simultaneously present in the left hip, right hip, and lumbar spine among nearly one fifth of patients. Our work highlights the importance of closely monitoring BMD in ART-naive patients and provides a foundation for the clinical intervention of bone demineralization in them.
format Online
Article
Text
id pubmed-7752695
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77526952020-12-23 Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study Zeng, Yong-Qin Xiao, Jiang Li, Cui-Lin Wang, Yu Zhang, Ling Pang, Xiao-Li Wang, Di Du, Juan Zhao, Hong-Xin Chin Med J (Engl) Original Articles BACKGROUND: Studies have reported that low bone mineral density (BMD) is prevalent in human immunodeficiency virus (HIV)-infected patients; however, the factors that contribute to HIV-related BMD changes are yet to be fully understood. Due to the application of dual X-ray absorptiometry (DXA) among a select group of hospitals only, the prevalence and risk factors of low BMD in HIV-infected populations have not been intensively investigated in China. Thus, the aim of our study was to investigate the prevalence of and risk factors associated with BMD changes among antiretroviral therapy (ART)-naive HIV-positive patients in China. METHODS: The assessment of the prevalence of and risk factors associated with BMD changes was conducted among 156 ART-naive HIV-infected patients. Demographic and clinical data, as well as results of fasting blood tests were obtained from patients. Further, all patients underwent DXA scans to determine BMD, which was then used to classify patients with osteopenia/osteoporosis. The risk factors of reduced BMD were then evaluated using binary logistic regression. RESULTS: Among the 156 ART-naive HIV-infected participants, osteopenia and osteoporosis were diagnosed in 48.7% (76/156) and 4.5% (7/156) of patients, respectively. The lumbar spine was most likely to have reduced BMD (49.4% [77/156]), and the proportion of osteopenia in the left hip (32.7% [51/156]) was higher than in the right hip (24.4% [38/156]). In the lumbar spine, bone loss rate in the L1 section (60.9% [95/156]) was the most significant (L2, 53.2% [83/156]; L3, 45.5% [71/156]; L4, 52.6% [82/156]). Further analysis showed that, compared with the neck (26.9% [42/156] in the left, 18.6% [29/156] in the right) and the interior (15.4% [24/156] in the left, 13.5% [21/156] in the right), the trochanter had the greatest probability of reduced BMD (46.2% [72/156] in the left, 28.8% [45/156] in the right). In the risk factor analysis, low body mass index (BMI: <18.5 kg/m(2)) was positively associated with reduced BMD (Exp (B) = 39.743, 95% confidence interval: 3.234–488.399, P = 0.004), and was specifically positively correlated with BMD values at three sites (r = 0.335 at right hip, r = 0.327 at left hip, r = 0.311 at lumbar spine). CONCLUSION: Reduced BMD was found in the majority of ART-naive HIV-infected patients and BMI was identified as an additional risk factor for reduced BMD. Our results show that BMD reduction was simultaneously present in the left hip, right hip, and lumbar spine among nearly one fifth of patients. Our work highlights the importance of closely monitoring BMD in ART-naive patients and provides a foundation for the clinical intervention of bone demineralization in them. Lippincott Williams & Wilkins 2020-12-20 2020-12-03 /pmc/articles/PMC7752695/ /pubmed/33278100 http://dx.doi.org/10.1097/CM9.0000000000001317 Text en Copyright © 2020 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Zeng, Yong-Qin
Xiao, Jiang
Li, Cui-Lin
Wang, Yu
Zhang, Ling
Pang, Xiao-Li
Wang, Di
Du, Juan
Zhao, Hong-Xin
Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study
title Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study
title_full Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study
title_fullStr Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study
title_full_unstemmed Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study
title_short Prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a Chinese cohort study
title_sort prevalence and risk factors for bone mineral density changes in antiretroviral therapy-naive human immunodeficiency virus-infected adults: a chinese cohort study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752695/
https://www.ncbi.nlm.nih.gov/pubmed/33278100
http://dx.doi.org/10.1097/CM9.0000000000001317
work_keys_str_mv AT zengyongqin prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT xiaojiang prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT licuilin prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT wangyu prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT zhangling prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT pangxiaoli prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT wangdi prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT dujuan prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy
AT zhaohongxin prevalenceandriskfactorsforbonemineraldensitychangesinantiretroviraltherapynaivehumanimmunodeficiencyvirusinfectedadultsachinesecohortstudy